Ischaemic breast necrosis following coronary artery bypass grafting using left internal mammary artery: understanding

Sandeep B1, Anmol Khanna1, Colin Song1

  • 1Department of Plastic Surgery, Fiona Stanley Hospital, Perth, Western Australia, Australia.

ANZ Journal of Surgery
|March 16, 2021
PubMed

Insights

Coronary artery bypass grafting (CABG) using the left internal mammary artery (LIMA) can lead to breast necrosis in obese patients with macromastia. Preoperative imaging and informed consent are crucial for managing this risk.

Area of Science:

  • Cardiovascular Surgery
  • Plastic Surgery
  • Surgical Complications

Background:

  • Coronary artery bypass grafting (CABG) frequently utilizes the left internal mammary artery (LIMA) for revascularization.
  • Sternal wound dehiscence and breast necrosis are rare but serious complications following LIMA harvest.
  • This study reports a case and reviews literature on breast necrosis post-CABG, particularly in patients with specific risk factors.

Observation:

  • A 55-year-old obese female with macromastia, diabetes, hypertension, and end-stage renal disease developed sternal wound dehiscence and breast necrosis after LIMA harvest.
  • A literature review identified 18 cases of breast necrosis post-CABG.
  • Affected patients were typically over 50, morbidly obese, had large breasts, and presented with delayed necrosis (≥7 days post-CABG), often in the lower inner quadrant.

Findings:

  • Reduced blood supply overlap in large breasts, combined with comorbidities like obesity, diabetes, and renal insufficiency, increases the risk of breast necrosis after LIMA harvest.
  • Necrosis characteristically affects the lower inner quadrant of the left breast, including the nipple-areola complex.
  • Delayed presentation of necrosis is common, often occurring a week or more after the initial surgery.

Implications:

  • Preoperative computed tomography angiography is recommended for patients with macromastia and comorbidities to assess breast vascularity before CABG.
  • Informed consent must explicitly address the risk of breast necrosis.
  • Surgical reduction or amputation for macromastia may be considered to mitigate risks if LIMA is essential, balancing risks and benefits.
Abstract